Bright light therapy for melanoma or lung cancer patients starting immunotherapy
Part of Cancer, Lungs & breathing, Skin clinical trials.
This study tests if daily bright light therapy can help people with advanced melanoma or lung cancer feel better during their first immunotherapy treatment. The light box is used at home for a short time each morning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced melanoma or non-small cell lung cancer that can't be removed with surgery.
- You are about to start your first immunotherapy treatment (like Keytruda or a combination).
- You are 18 or older and can use the internet at home.
- You are not using melatonin or prescription sleep aids, and do not have certain eye conditions.
- You do not have bipolar disorder, recent psychosis, or poorly controlled seizures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a simple blood test to see if it can predict how well your cancer will respond to immunotherapy. You will give blood samples before and during treatment, and the researchers will analyze small particles in your blood to find clues about your likely response.
This early trial tests CBL0137 along with ipilimumab and nivolumab (two immune-based cancer medicines) in people with stage III or possibly stage IV melanoma that can be biopsied. It may help shrink melanoma and improve immune control, while also learning how safe and effective this combination is.
This trial tests whether injecting immune-boosting drugs directly into melanoma tumors, alongside the immunotherapy pembrolizumab, can help people whose cancer has not responded to previous immunotherapy. It aims to shrink tumors and improve treatment outcomes.
This trial tests a special bright light therapy designed to help your body's natural sleep-wake cycle. It is being studied for people with advanced melanoma who are about to receive TIL therapy, a treatment that uses your own immune cells to fight the cancer. The light therapy might help improve how you feel during treatment.
This trial tests whether a structured bright-light exposure routine combined with a specific exercise program can help people with newly diagnosed lung or esophageal cancer. You may be eligible if you’re in early-to-middle cancer stages and able to safely participate in walking-based activities.
This trial studies whether a structured light-exposure routine can improve symptoms like fatigue and how survivors feel day to day. It is aimed at children and teens who have recovered from a non–high-risk type of brain tumor and have mild to moderate fatigue.
Hear when a new Melanoma (Skin Cancer) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.